Literature DB >> 20830649

Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline.

Sarah A Morrow1, Allison Drake, Robert Zivadinov, Frederick Munschauer, Bianca Weinstock-Guttman, Ralph H B Benedict.   

Abstract

Cognitive dysfunction is common in multiple sclerosis (MS), yet the magnitude of change on objective neuropsychological (NP) tests that is clinically meaningful is unclear. We endeavored to determine NP markers of the transition from employment to work disability in MS, as indicated by degree of decline on individual tests. Participants were 97 employed MS patients followed over 41.3 ± 17.6 months with a NP battery covering six domains of cognitive function. Deterioration at follow-up was designated as documented and paid disability benefits (conservative definition) or a reduction in hours/work responsibilities (liberal definition). Using the conservative definition, 28.9% reported deteriorated employment status and for the liberal definition, 45.4%. The Symbol Digit Modalities Test (SDMT) and California Verbal Learning Test, Total Learning (CVLT2-TL) measures distinguished employed and disabled patients at follow-up. Controlling for demographic and MS characteristics, the odds ratio of a deterioration based on a change of 2.0 on the CVLT2-TL was 3.7 (95% CI 1.2-11.4 and SDMT by 4.0 was 4.2 (95% CI 1.2-14.8), accounting for 86.7% of the area under the ROC curve. We conclude that decline on NP testing over time is predictive of deterioration in vocational status, establishing a magnitude of decline on NP tests that is clinically meaningful.

Entities:  

Mesh:

Year:  2010        PMID: 20830649     DOI: 10.1080/13854046.2010.511272

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  65 in total

1.  Longitudinal changes in social functioning in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II).

Authors:  Francesco Patti; Maria Pia Amato; Maria Trojano; Stefano Bastianello; Maria Rosalia Tola; Orietta Picconi; Sabina Cilia; Salvatore Cottone; Luigi M E Grimaldi
Journal:  Qual Life Res       Date:  2011-09-28       Impact factor: 4.147

2.  Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome.

Authors:  Tomas Uher; Jana Blahova-Dusankova; Dana Horakova; Niels Bergsland; Michaela Tyblova; Ralph H B Benedict; Tomas Kalincik; Deepa P Ramasamy; Zdenek Seidl; Jesper Hagermeier; Manuela Vaneckova; Jan Krasensky; Eva Havrdova; Robert Zivadinov
Journal:  J Neurol       Date:  2014-06-22       Impact factor: 4.849

3.  Cognition and physical disability in predicting health-related quality of life in multiple sclerosis.

Authors:  Marietta Hoogs; Sukhmit Kaur; Audrey Smerbeck; Bianca Weinstock-Guttman; Ralph H B Benedict
Journal:  Int J MS Care       Date:  2011

4.  Protocol for a systematically-developed, phase I/II, single-blind randomized controlled trial of treadmill walking exercise training effects on cognition and brain function in persons with multiple sclerosis.

Authors:  Brian M Sandroff; M David Diggs; Marcas M Bamman; Gary R Cutter; Jessica F Baird; C Danielle Jones; John R Rinker; Glenn R Wylie; John DeLuca; Robert W Motl
Journal:  Contemp Clin Trials       Date:  2019-11-05       Impact factor: 2.226

Review 5.  Functional Electrical Stimulation Cycling Exercise for People with Multiple Sclerosis.

Authors:  Lara A Pilutti; Robert W Motl
Journal:  Curr Treat Options Neurol       Date:  2019-11-08       Impact factor: 3.598

6.  Remote assessment of verbal memory in MS patients using the California Verbal Learning Test.

Authors:  Lisa F Barcellos; Kalliope H Bellesis; Ling Shen; Xiaorong Shao; Terrence Chinn; Seth Frndak; Allison Drake; Nandini Bakshi; Jackie Marcus; Catherine Schaefer; Ralph Hb Benedict
Journal:  Mult Scler       Date:  2017-02-01       Impact factor: 6.312

7.  Cognitive assessment in multiple sclerosis-an Italian consensus.

Authors:  Maria Pia Amato; Vincenzo Brescia Morra; Monica Falautano; Angelo Ghezzi; Benedetta Goretti; Francesco Patti; Alice Riccardi; Flavia Mattioli
Journal:  Neurol Sci       Date:  2018-05-15       Impact factor: 3.307

8.  Randomized controlled trial of physical activity, cognition, and walking in multiple sclerosis.

Authors:  Brian M Sandroff; Rachel E Klaren; Lara A Pilutti; Deirdre Dlugonski; Ralph H B Benedict; Robert W Motl
Journal:  J Neurol       Date:  2013-12-10       Impact factor: 4.849

9.  The educational impact of childhood-onset multiple sclerosis: Why assessing academic achievement is imperative.

Authors:  W S Vargas; K G Noble; B Banwell; P De Jager
Journal:  Mult Scler       Date:  2020-05-28       Impact factor: 6.312

10.  Effects of single dose mixed amphetamine salts--extended release on processing speed in multiple sclerosis: a double blind placebo controlled study.

Authors:  Sarah A Morrow; Heather Rosehart
Journal:  Psychopharmacology (Berl)       Date:  2015-08-21       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.